Edition:
NIAID Funding News provides funding, policy, and other information to NIAID's extramural research community and Institute staff. You can subscribe directly by entering your email address at Email Updates and then selecting your subscription topics. Visit Stay Informed About Policy Changes and News for more opportunities to connect with us.
Small Businesses—Set Your Sights on Phase III
Though NIAID does not fund small businesses directly for commercialization, our aim is to set up small businesses for later success during the earlier phases of the Small Business Innovation Research and Small Business Technology Transfer programs.
Opportunities and Resources
Apply if you can develop mechanistic insights into innate and adaptive immune function changes that occur during the aging process in humans.
Help NIAID advance research to identify new antivirals that can eliminate hepatitis B virus (HBV) and covalently closed circular DNA (cccDNA) from infected cells to effect a functional cure.
Our notice of special interest (NOSI) aims to stimulate multidisciplinary research that targets the pathogen within the invertebrate host to prevent its transmission to the vertebrate host.
In The News
An interim payline is an administrative measure that allows us get some top-scoring grants out the door while we wait for our appropriation.
NIAID participates in four Loan Repayment Programs, specifically those for clinical research, pediatric research, health disparities research, and research in emerging areas critical to human health.
Your organization's annual vertebrate animal report should cover the 2022 fiscal year, and your institutional official must send the signed report by December 1, 2022.
Advice Corner
Each funding opportunity announcement has an Eligibility section that indicates whether foreign institutions, foreign components of U.S. institutions, or foreign components are allowed to apply.
Contact Us
Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.